Advertisement
Screener

CVS HEALTH CORPORATION (CVS) Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest

2.3 / 5 stars · 55/120 Roast Me

CVS HEALTH CORPORATION Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest

CVS HEALTH CORPORATION (CVS) reported Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest of $2.98 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Income Statement › Unrealized Gains

us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-08-05

  • CVS HEALTH CORPORATION comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for the quarter ending 2026-06-30 was $2.98B, a 143.23% increase year-over-year.
  • CVS HEALTH CORPORATION comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for the quarter ending 2026-03-31 was $2.75B, a 40.34% increase year-over-year.
  • CVS HEALTH CORPORATION comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for the quarter ending 2025-12-31 was $2.91B, a 125.12% increase year-over-year.
  • CVS HEALTH CORPORATION comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for the quarter ending 2025-09-30 was -$3.85B, a 742.07% decline year-over-year.
  • CVS HEALTH CORPORATION comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for fiscal 2025 was $2.25B, a 52.68% decline from fiscal 2024.
  • CVS HEALTH CORPORATION comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for fiscal 2024 was $4.76B, a 48.98% decline from fiscal 2023.
  • CVS HEALTH CORPORATION comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for fiscal 2023 was $9.34B, a 242.07% increase from fiscal 2022.
  • CVS HEALTH CORPORATION comprehensive income (loss), net of tax, including portion attributable to noncontrolling interest for fiscal 2022 was $2.73B, a 64.44% decline from fiscal 2021.
Period endComprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 monthComprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month as first filedComprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 monthComprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month as first filedComprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 monthComprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month as first filedComprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 monthComprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month as first filed
2026-06-30$2.98B
10-Q · filed 2026-08-05
$5.73B
10-Q · filed 2026-08-05
$8.65B
derived: sum of 3 quarters · filed 2026-08-05
$4.80B
derived: sum of 4 quarters · filed 2026-08-05
2026-03-31$2.75B
10-Q · filed 2026-05-06
$5.67B
derived: sum of 2 quarters · filed 2026-05-06
$1.82B
derived: sum of 3 quarters · filed 2026-05-06
$3.04B
derived: sum of 4 quarters · filed 2026-08-05
2025-12-31$2.91B
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10
-$933.00M
derived: sum of 2 quarters · filed 2026-02-10
$293.00M
derived: sum of 3 quarters · filed 2026-08-05
$2.25B
10-K · filed 2026-02-10
2025-09-30-$3.85B
10-Q · filed 2025-10-29
-$2.62B
derived: sum of 2 quarters · filed 2026-08-05
-$659.00M
10-Q · filed 2025-10-29
$635.00M
derived: sum of 4 quarters · filed 2026-08-05
2025-06-30$1.23B
10-Q · filed 2026-08-05
$3.19B
10-Q · filed 2026-08-05
$4.48B
derived: sum of 3 quarters · filed 2026-08-05
$5.08B
derived: sum of 4 quarters · filed 2026-08-05
2025-03-31$1.96B
10-Q · filed 2026-05-06
$3.25B
derived: sum of 2 quarters · filed 2026-05-06
$3.85B
derived: sum of 3 quarters · filed 2026-05-06
$5.64B
derived: sum of 4 quarters · filed 2026-05-06
2024-12-31$1.29B
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10
$1.89B
derived: sum of 2 quarters · filed 2026-02-10
$3.68B
derived: sum of 3 quarters · filed 2026-02-10
$4.76B
10-K · filed 2026-02-10
2024-09-30$599.00M
10-Q · filed 2025-10-29
$2.39B
derived: sum of 2 quarters · filed 2025-10-29
$3.47B
10-Q · filed 2025-10-29
$6.22B
derived: sum of 4 quarters · filed 2026-02-10
2024-06-30$1.79B
10-Q · filed 2025-07-31
$2.87B
10-Q · filed 2025-07-31
$5.62B
derived: sum of 3 quarters · filed 2026-02-10
$7.74B
derived: sum of 4 quarters · filed 2026-02-10
2024-03-31$1.08B
10-Q · filed 2025-05-01
$3.83B
derived: sum of 2 quarters · filed 2026-02-10
$5.95B
derived: sum of 3 quarters · filed 2026-02-10
$7.88B
derived: sum of 4 quarters · filed 2026-02-10
2023-12-31$2.75B
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10
$4.87B
derived: sum of 2 quarters · filed 2026-02-10
$6.80B
derived: sum of 3 quarters · filed 2026-02-10
$9.34B
10-K · filed 2026-02-10
2023-09-30$2.12B
10-Q · filed 2024-11-06
$4.05B
derived: sum of 2 quarters · filed 2024-11-06
$6.58B
10-Q · filed 2024-11-06
$9.00B
derived: sum of 4 quarters · filed 2025-02-12
2023-06-30$1.93B
10-Q · filed 2024-08-07
$4.46B
10-Q · filed 2024-08-07
$6.88B
derived: sum of 3 quarters · filed 2025-02-12
$3.10B
derived: sum of 4 quarters · filed 2025-02-12
2023-03-31$2.53B
10-Q · filed 2024-05-01
$4.95B
derived: sum of 2 quarters · filed 2025-02-12
$1.17B
derived: sum of 3 quarters · filed 2025-02-12
$3.67B
derived: sum of 4 quarters · filed 2025-02-12
2022-12-31$2.42B
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12
-$1.36B
derived: sum of 2 quarters · filed 2025-02-12
$1.14B
derived: sum of 3 quarters · filed 2025-02-12
$2.73B
10-K · filed 2025-02-12
$1.74B
10-K · filed 2023-02-08
2022-09-30-$3.78B
10-Q · filed 2023-11-01
-$4.03B
10-Q · filed 2022-11-02
-$1.28B
derived: sum of 2 quarters · filed 2023-11-01
$307.00M
10-Q · filed 2023-11-01
-$709.00M
10-Q · filed 2022-11-02
$1.72B
derived: sum of 4 quarters · filed 2024-02-07
2022-06-30$2.50B
10-Q · filed 2023-08-02
$2.16B
10-Q · filed 2022-08-03
$4.09B
10-Q · filed 2023-08-02
$3.32B
10-Q · filed 2022-08-03
$5.50B
derived: sum of 3 quarters · filed 2024-02-07
$7.00B
derived: sum of 4 quarters · filed 2024-02-07
2022-03-31$1.59B
10-Q · filed 2023-05-03
$1.16B
10-Q · filed 2022-05-04
$3.00B
derived: sum of 2 quarters · filed 2024-02-07
$4.50B
derived: sum of 3 quarters · filed 2024-02-07
$7.43B
derived: sum of 4 quarters · filed 2024-02-07
2021-12-31$1.41B
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-07
$2.90B
derived: sum of 2 quarters · filed 2024-02-07
$5.84B
derived: sum of 3 quarters · filed 2024-02-07
$7.67B
10-K · filed 2024-02-07
$7.45B
10-K · filed 2022-02-09
2021-09-30$1.49B
10-Q · filed 2022-11-02
$4.43B
derived: sum of 2 quarters · filed 2022-11-02
$6.26B
10-Q · filed 2022-11-02
$7.40B
derived: sum of 4 quarters · filed 2023-05-25
2021-06-30$2.94B
10-Q · filed 2022-08-03
$4.77B
10-Q · filed 2022-08-03
$5.91B
derived: sum of 3 quarters · filed 2023-05-25
$7.17B
derived: sum of 4 quarters · filed 2023-05-25
2021-03-31$1.83B
10-Q · filed 2022-05-04
$2.97B
derived: sum of 2 quarters · filed 2023-05-25
$4.23B
derived: sum of 3 quarters · filed 2023-05-25
$7.74B
derived: sum of 4 quarters · filed 2023-05-25
2020-12-31$1.13B
derived: 8-K 12 month − 10-Q 9 month · filed 2023-05-25
$2.40B
derived: sum of 2 quarters · filed 2023-05-25
$5.91B
derived: sum of 3 quarters · filed 2023-05-25
$7.59B
8-K · filed 2023-05-25
2020-09-30$1.26B
10-Q · filed 2021-11-03
$4.77B
derived: sum of 2 quarters · filed 2021-11-03
$6.45B
10-Q · filed 2021-11-03
$8.27B
derived: sum of 4 quarters · filed 2022-02-09
2020-06-30$3.51B
10-Q · filed 2021-08-04
$5.19B
10-Q · filed 2021-08-04
$7.00B
derived: sum of 3 quarters · filed 2022-02-09
$8.80B
derived: sum of 4 quarters · filed 2022-02-09
2020-03-31$1.68B
10-Q · filed 2021-05-04
$3.49B
derived: sum of 2 quarters · filed 2022-02-09
$5.29B
derived: sum of 3 quarters · filed 2022-02-09
$7.47B
derived: sum of 4 quarters · filed 2022-02-09
2019-12-31$1.81B
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09
$3.61B
derived: sum of 2 quarters · filed 2022-02-09
$5.79B
derived: sum of 3 quarters · filed 2022-02-09
$7.55B
10-K · filed 2022-02-09
2019-09-30$1.79B
10-Q · filed 2020-11-06
$3.98B
derived: sum of 2 quarters · filed 2020-11-06
$5.74B
10-Q · filed 2020-11-06
$5.29B
derived: sum of 4 quarters · filed 2021-02-16
2019-06-30$2.18B
10-Q · filed 2020-08-05
$3.94B
10-Q · filed 2020-08-05
$3.49B
derived: sum of 3 quarters · filed 2021-02-16
$4.87B
derived: sum of 4 quarters · filed 2021-02-16
2019-03-31$1.76B
10-Q · filed 2020-05-06
$1.31B
derived: sum of 2 quarters · filed 2021-02-16
$2.69B
derived: sum of 3 quarters · filed 2021-02-16
$94.00M
derived: sum of 4 quarters · filed 2021-02-16
2018-12-31-$448.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16
$930.00M
derived: sum of 2 quarters · filed 2021-02-16
-$1.66B
derived: sum of 3 quarters · filed 2021-02-16
-$322.00M
10-K · filed 2021-02-16
2018-09-30$1.38B
10-Q · filed 2019-11-06
-$1.22B
derived: sum of 2 quarters · filed 2019-11-06
$126.00M
10-Q · filed 2019-11-06
$3.40B
derived: sum of 4 quarters · filed 2020-02-18
2018-06-30-$2.59B
10-Q · filed 2019-08-07
-$1.25B
10-Q · filed 2019-08-07
$2.02B
derived: sum of 3 quarters · filed 2020-02-18
$3.46B
derived: sum of 4 quarters · filed 2020-02-18
2018-03-31$1.34B
10-Q · filed 2019-05-01
$4.61B
derived: sum of 2 quarters · filed 2020-02-18
$6.05B
derived: sum of 3 quarters · filed 2020-02-18
$7.14B
derived: sum of 4 quarters · filed 2020-02-18
2017-12-31$3.27B
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18
$4.71B
derived: sum of 2 quarters · filed 2020-02-18
$5.80B
derived: sum of 3 quarters · filed 2020-02-18
$6.76B
10-K · filed 2020-02-18
2017-09-30$1.44B
10-Q · filed 2018-11-06
$2.53B
derived: sum of 2 quarters · filed 2018-11-06
$3.49B
10-Q · filed 2018-11-06
$5.21B
derived: sum of 4 quarters · filed 2019-08-08
2017-06-30$1.09B
10-Q · filed 2018-08-08
$2.05B
10-Q · filed 2018-08-08
$3.77B
derived: sum of 3 quarters · filed 2019-08-08
$5.31B
derived: sum of 4 quarters · filed 2019-08-08
2017-03-31$962.00M
10-Q · filed 2018-05-02
$2.68B
derived: sum of 2 quarters · filed 2019-08-08
$4.22B
derived: sum of 3 quarters · filed 2019-08-08
$5.17B
derived: sum of 4 quarters · filed 2019-08-08
2016-12-31$1.72B
derived: 8-K 12 month − 10-Q 9 month · filed 2019-08-08
$3.26B
derived: sum of 2 quarters · filed 2019-08-08
$4.21B
derived: sum of 3 quarters · filed 2019-08-08
$5.37B
8-K · filed 2019-08-08
2016-09-30$1.54B
10-Q · filed 2017-11-06
$2.48B
derived: sum of 2 quarters · filed 2017-11-06
$3.65B
10-Q · filed 2017-11-06
$5.11B
derived: sum of 4 quarters · filed 2018-02-14
2016-06-30$946.00M
10-Q · filed 2017-08-08
$2.11B
10-Q · filed 2017-08-08
$3.57B
derived: sum of 3 quarters · filed 2018-02-14
$4.75B
derived: sum of 4 quarters · filed 2018-02-14
2016-03-31$1.17B
10-Q · filed 2017-05-02
$2.62B
derived: sum of 2 quarters · filed 2018-02-14
$3.81B
derived: sum of 3 quarters · filed 2018-02-14
$5.09B
derived: sum of 4 quarters · filed 2018-02-14
2015-12-31$1.46B
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-14
$2.64B
derived: sum of 2 quarters · filed 2018-02-14
$3.92B
derived: sum of 3 quarters · filed 2018-02-14
$5.10B
10-K · filed 2018-02-14
2015-09-30$1.19B
10-Q · filed 2016-11-08
$2.47B
derived: sum of 2 quarters · filed 2016-11-08
$3.64B
10-Q · filed 2016-11-08
$4.91B
derived: sum of 4 quarters · filed 2017-02-09
2015-06-30$1.28B
10-Q · filed 2016-08-02
$2.46B
10-Q · filed 2016-08-02
$3.72B
derived: sum of 3 quarters · filed 2017-02-09
$4.64B
derived: sum of 4 quarters · filed 2017-02-09
2015-03-31$1.17B
10-Q · filed 2016-05-03
$2.44B
derived: sum of 2 quarters · filed 2017-02-09
$3.36B
derived: sum of 3 quarters · filed 2017-02-09
$4.61B
derived: sum of 4 quarters · filed 2017-02-09
2014-12-31$1.26B
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-09
$2.18B
derived: sum of 2 quarters · filed 2017-02-09
$3.44B
derived: sum of 3 quarters · filed 2017-02-09
$4.58B
10-K · filed 2017-02-09
2014-09-30$920.00M
10-Q · filed 2015-10-30
$2.17B
derived: sum of 2 quarters · filed 2015-10-30
$3.31B
10-Q · filed 2015-10-30
$4.62B
derived: sum of 4 quarters · filed 2016-02-09
2014-06-30$1.25B
10-Q · filed 2015-08-04
$2.39B
10-Q · filed 2015-08-04
$3.70B
derived: sum of 3 quarters · filed 2016-02-09
$4.96B
derived: sum of 4 quarters · filed 2016-02-09
2014-03-31$1.14B
10-Q · filed 2015-05-01
$2.45B
derived: sum of 2 quarters · filed 2016-02-09
$3.70B
derived: sum of 3 quarters · filed 2016-02-09
$4.81B
derived: sum of 4 quarters · filed 2016-02-09
2013-12-31$1.31B
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-09
$2.56B
derived: sum of 2 quarters · filed 2016-02-09
$3.67B
derived: sum of 3 quarters · filed 2016-02-09
$4.62B
10-K · filed 2016-02-09
2013-09-30$1.25B
10-Q · filed 2014-11-04
$1.26B
10-Q · filed 2013-11-05
$2.36B
derived: sum of 2 quarters · filed 2014-11-04
$3.31B
10-Q · filed 2014-11-04
$3.32B
10-Q · filed 2013-11-05
$4.42B
derived: sum of 4 quarters · filed 2015-02-10
2013-06-30$1.11B
10-Q · filed 2014-08-05
$1.10B
10-Q · filed 2013-08-06
$2.06B
10-Q · filed 2014-08-05
$2.06B
10-Q · filed 2013-08-06
$3.16B
derived: sum of 3 quarters · filed 2015-02-10
$4.17B
derived: sum of 4 quarters · filed 2015-02-10
2013-03-31$953.00M
10-Q · filed 2014-05-02
$955.00M
10-Q · filed 2013-05-01
$2.06B
derived: sum of 2 quarters · filed 2015-02-10
$3.06B
derived: sum of 3 quarters · filed 2015-02-10
$4.03B
derived: sum of 4 quarters · filed 2015-02-10
2012-12-31$1.10B
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-10
$2.11B
derived: sum of 2 quarters · filed 2015-02-10
$3.08B
derived: sum of 3 quarters · filed 2015-02-10
$3.85B
10-K · filed 2015-02-10
$3.87B
10-K · filed 2013-02-15
2012-09-30$1.01B
10-Q · filed 2013-11-05
$1.97B
derived: sum of 2 quarters · filed 2013-11-05
$2.75B
10-Q · filed 2013-11-05
$3.79B
derived: sum of 4 quarters · filed 2014-02-11
2012-06-30$966.00M
10-Q · filed 2013-08-06
$1.74B
10-Q · filed 2013-08-06
$2.79B
derived: sum of 3 quarters · filed 2014-02-11
$3.66B
derived: sum of 4 quarters · filed 2014-02-11
2012-03-31$777.00M
10-Q · filed 2013-05-01
$1.82B
derived: sum of 2 quarters · filed 2014-02-11
$2.69B
derived: sum of 3 quarters · filed 2014-02-11
$3.50B
derived: sum of 4 quarters · filed 2014-02-11
2011-12-31$1.04B
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-11
$1.91B
derived: sum of 2 quarters · filed 2014-02-11
$2.72B
derived: sum of 3 quarters · filed 2014-02-11
$3.43B
10-K · filed 2014-02-11
$3.43B
10-K · filed 2013-02-15
2011-09-30$869.00M
10-Q · filed 2012-11-06
$868.00M
10-Q · filed 2011-11-03
$1.68B
derived: sum of 2 quarters · filed 2012-11-06
$2.39B
10-Q · filed 2012-11-06
$2.38B
10-Q · filed 2011-11-03
$3.41B
derived: sum of 4 quarters · filed 2013-02-15
2011-06-30$806.00M
10-Q · filed 2012-08-07
$805.00M
10-Q · filed 2011-08-04
$1.52B
10-Q · filed 2012-08-07
$1.52B
10-Q · filed 2011-08-04
$2.54B
derived: sum of 3 quarters · filed 2013-02-15
$3.35B
derived: sum of 4 quarters · filed 2013-02-15
2011-03-31$713.00M
10-Q · filed 2012-05-02
$712.00M
10-Q · filed 2011-05-05
$1.73B
derived: sum of 2 quarters · filed 2013-02-15
$2.54B
derived: sum of 3 quarters · filed 2013-02-15
$3.36B
derived: sum of 4 quarters · filed 2013-02-15
2010-12-31$1.02B
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-15
$1.83B
derived: sum of 2 quarters · filed 2013-02-15
$2.64B
derived: sum of 3 quarters · filed 2013-02-15
$3.42B
10-K · filed 2013-02-15
2010-09-30$808.00M
10-Q · filed 2011-11-03
$1.63B
derived: sum of 2 quarters · filed 2011-11-03
$2.40B
10-Q · filed 2011-11-03
2010-06-30$818.00M
10-Q · filed 2011-08-04
$1.59B
10-Q · filed 2011-08-04
2010-03-31$775.00M
10-Q · filed 2011-05-05
2009-09-30$1.02B
10-Q · filed 2010-11-03
$1.91B
derived: sum of 2 quarters · filed 2010-11-03
$2.65B
10-Q · filed 2010-11-03
2009-06-30$887.00M
10-Q · filed 2010-07-29
$1.63B
10-Q · filed 2010-07-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
PETMED EXPRESS INC (PETS)United States$0.034B-1.41